Written question asked by Baroness Ritchie of Downpatrick (Labour) on Tuesday, 2 September 2025, in the House of Lords. It was due for an answer on Tuesday, 16 September 2025. It was answered by Baroness Merron (Labour) on Wednesday, 10 September 2025 on behalf of the Department of Health and Social Care.
Blood Transfusions
- Question
-
To ask His Majesty's Government whether the apheresis working group plans to consult external stakeholders, including patient organisations and the life sciences industry, prior to publishing the apheresis review.
- Answer
-
The apheresis working group was established in 2024 to provide independent advice to the Department on issues around apheresis capacity and the resilience of the United Kingdom’s stem cell supply. Membership includes the UK aligned stem cell registry, health professionals, and service providers. Stakeholder views have been captured through member organisations, including the Cell and Gene Therapy Catapult and blood cancer charities, and industry representatives have also been invited to present at meetings of the group.
There are no plans to consult external stakeholders prior to the publication of the group’s review of apheresis capacity. The group will look at options for formalising feedback following publication.
Secondary information
- Type
- Written question
- Reference
- HL10142
- Session
- 2024-26
- Subjects
- Blood transfusions
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2025-10-02 13:56:31 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/lords/2024-25/HL10142
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/lords/2024-25/HL10142
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/lords/2024-25/HL10142